Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study. - Aghemo, Alessio; Persico, Marcello; D'Ambrosio, Roberta; Andreoni, Massimo; Villa, Erica; Bhagat, Abhi; Gallinaro, Valentina; Gualberti, Giuliana; Merolla, Rocco Cosimo Damiano; Gasbarrini, Antonio (PLoS ONE, 2023)